Abstract 2012: Recurrent rearrangements of NAALADL2 in prostate, breast, cervical, head and neck and lung squamous cell carcinoma
Pavithra D. Arachchige(Henry Ford Health System), Nallasivam Palanisamy(Henry Ford Health System), Tarek A. Bismar(University of Calgary), Craig Rogers(Norfolk and Norwich University Hospitals NHS Foundation Trust), Dhananjay Chitale(Henry Ford Hospital), James Hu(University of Southern California), Darshan S. Chandrashekar(University of Alabama at Birmingham), Evelyn Jiagge(Henry Ford Health System), Sooryanarayana Varambally(University of Alabama at Birmingham), James O. Peabody(Henry Ford Hospital), Nilesh Gupta(Henry Ford Health System), Mani Menon(Henry Ford Hospital), Sean R. Williamson(Cleveland Clinic), Shannon Carskadon(Henry Ford Health System), Justin Fernando(Henry Ford Health System)
Cited by 2
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
|Nature Communications|2019|567